In-person clinical trials have been essential for medical researchers. Participants would travel to hospitals or research centers, fill out paperwork, and meet one-on-one with clinicians — until the coronavirus pandemic impeded those efforts. Many clinical trials have since become virtual, which may be considered advantageous, as more people can partake without the hassles. In fact, Dr. Reynold Panettieri, vice chancellor for translational medicine and science at Rutgers University, believes online trials may be here to stay. To read the full story.
COVID-19 is changing the way clinical trials are conducted
